Region: Latin America & Caribbean

Meet the new faces in the IP Hall of Fame

This year’s inductees share what it takes to become the best of the best

12 August 2020

How compulsory patent licensing could be used to combat covid-19 in the Americas

As the race to find coronavirus cures intensifies, we explore how legislation might be deployed in Brazil, Canada, Mexico and the US to ensure inventions are shared

05 August 2020

The advantages and disadvantages of WIPO PROOF

The World Intellectual Property Organization rolled out its new timestamping solution in May and while it has a lot going for it, there are downsides too

19 June 2020

Takeda offloads yet more “non-core” assets with other deals likely to follow

The Japanese big pharma continues to divest drug rights to pay down its debt and fund desperately needed innovation

18 June 2020

How IAM will bring together global IP leaders this September

Join us for IPBC Connect – best-in-class value creation strategies, coming to you from the people who know, throughout the month

17 June 2020

We name the world's top patent lawyers, attorneys, practices and firms

The 2020 edition of the IAM Patent 1000 features in-depth analysis of the markets in 48 key jurisdictions and is based on thousands of submissions, interviews and client references

11 June 2020

The US and Germany top for patent litigation, say survey respondents

IAM benchmarking results send mixed messages about the UK, but show increasing interest in China, India and Brazil

10 June 2020

IAM benchmarking survey 2020

Featured in Community Insight

Our annual snapshot of the industry keeps the EPO at the top of the big five but suggests that the shine may have come off Andrei Iancu’s reign

08 June 2020

Global calls for compulsory covid-19 patent licensing build

Scrutiny of biopharma innovators’ coronavirus IP strategies will continue to intensify in coming months as concerns mount about access to treatments

21 May 2020

Regulatory framework – healthcare products and intellectual property in Mexico

Featured in IAM Life Sciences: Key issues for senior life sciences executives 2020

With Mexico’s change of government, new trends and practices have been introduced, affecting, among other things, the regulatory and IP framework. This chapter contains an overview of the main ammendments made throughout 2019 and a brief discussion on what it is expected for 2020.

07 May 2020

Unlock unlimited access to all IAM content